PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Discovery of HIV 'invisibility cloak' reveals new treatment opportunities

2013-11-07
(Press-News.org) Contact information: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust
Discovery of HIV 'invisibility cloak' reveals new treatment opportunities Scientists have discovered a molecular invisibility cloak that enables HIV, the virus that causes AIDS, to hide inside cells of the body without triggering the body's natural defence systems.

Their study shows how 'uncloaking' the virus using an experimental drug triggers an immune response that stops the virus from replicating in cells grown in the laboratory.

The findings could lead to new treatments and help to improve existing therapies for HIV infection.

The innate immune system is the body's first line of defence against infection and incorporates an alarm system present in all cells of the body that detects the presence of 'foreign' material from invading bacteria and viruses. When the alarm is tripped, the infected cell begins an anti-viral programme and sends out warning signals to alert other cells that a virus is around. HIV infects vital cells of the immune system so its ability to replicate undetected without triggering this alarm system has puzzled scientists since the discovery of the virus.

The team identified two molecules inside host cells that are recruited by HIV after infection that stop the virus from reproducing its genetic material too early. The effect is to shield the virus from the alarm system and stop the innate immune system from kicking into action.

In the absence of these molecules, either by depletion from infected cells or blocking their recruitment using an experimental drug, HIV is exposed to the alarm system and an anti-virus immune response is triggered. Targeting the cloaking molecules and not the virus itself makes it much more difficult for the virus to mutate and become resistant to this treatment approach, a significant problem with standard HIV therapies.

Professor Greg Towers, a Wellcome Trust Senior Research Fellow at UCL and lead author of the study, said: "HIV is extremely adept at hiding from our body's natural defences, which is part of the reason the virus is so dangerous. Now we've identified the virus' invisibility cloak, and how to expose it, we've uncovered a weakness that could be exploited for new HIV treatments.

"There's a great deal more research needed but the potential for this approach is huge, as a possible treatment in itself but also as a complement to existing therapies. We're also interested to see whether blocking these cloaking molecules can help to boost immune responses to experimental vaccines against HIV or be used to protect against HIV transmission.

"The hope is that one day we may be able develop a treatment that helps the body to clear the virus before the infection is able to take hold."

The experimental drug used in the study is based on Cyclosporine, a drug that is widely used to prevent organ rejection in transplant patients because of its ability to dampen the immune response. Cyclosporines have been shown to block the replication of HIV and other viruses but are not suitable for treating infected patients because of their negative effects on the immune system. The team used a modified version of the drug, which blocks the effects of the two cloaking molecules without suppressing immune activity.

Dr Kevin Moses, Director of Science Funding at the Wellcome Trust said: "In 2012, 2.3 million people were newly infected with HIV. Whilst existing treatments are helping people with HIV to live longer and healthier lives, the challenge of adherence to treatment programmes means that drug resistance remains a threat and the virus continues to burden the world's poorest communities. Understanding how HIV interacts with the body's own defences might just be crucial for developing the best approaches to therapy."

### The study is published today in the journal Nature and was funded by the Wellcome Trust, the Medical Research Council and the National Institute for Health Research University College London Hospitals Biomedical Research Centre.


ELSE PRESS RELEASES FROM THIS DATE:

Study uncovers new explanation for infection susceptibility in newborns

2013-11-07
Study uncovers new explanation for infection susceptibility in newborns CINCINNATI – Cells that allow helpful bacteria to safely colonize the intestines of newborn infants also suppress their immune systems to make them more vulnerable ...

Newly discovered predatory dinosaur 'king of gore' reveals the origins of T. rex

2013-11-07
Newly discovered predatory dinosaur 'king of gore' reveals the origins of T. rex November 6, 2013, Salt Lake City, UT – A remarkable new species of tyrannosaur has been unearthed in Grand Staircase-Escalante National Monument (GSENM), southern Utah. The huge ...

New study identifies signs of autism in the first months of life

2013-11-07
New study identifies signs of autism in the first months of life Scientists at Marcus Autism Center, Children's Healthcare of Atlanta and Emory University School of Medicine identify markers of social disability present in 2 to 6-month-old infants later diagnosed ...

RNA controls splicing during gene expression, further evidence of 'RNA world' origin in modern life

2013-11-07
RNA controls splicing during gene expression, further evidence of 'RNA world' origin in modern life RNA is the key functional component of spliceosomes, molecular machines that control how genes are expressed, report scientists from the University ...

New research shows clear association between ACE inhibitors and acute kidney injury

2013-11-07
New research shows clear association between ACE inhibitors and acute kidney injury These and similar drugs are the second most prescribed on the NHS Cambridge scientists have found an association between ACE inhibitors (and similar drugs) and acute kidney ...

First study of Russian meteor

2013-11-07
First study of Russian meteor The meteor that exploded over Chelyabinsk, Russia in February 2013 was "a wake-up call," according to a University of California, Davis scientist who participated in analyzing the event. The work is published Nov. 7 in the journal ...

Climate change scientists must turn their attention to clean skies

2013-11-07
Climate change scientists must turn their attention to clean skies Natural aerosols, such as emissions from volcanoes or plants, may contribute more uncertainty than previously thought to estimates of how the climate might respond to greenhouse gas emissions. An ...

Drilling for hydrocarbons can impact aquatic life

2013-11-07
Drilling for hydrocarbons can impact aquatic life Drilling sumps can leak into surface water The degradation of drilling sumps associated with hydrocarbon extraction can negatively affect aquatic ecosystems, according to new research published November 6th in the open-access ...

The presence of human settlements has a negative impact on tiger connectivity

2013-11-07
The presence of human settlements has a negative impact on tiger connectivity Tigers are dispersing over much greater distances than previously found Human settlements and roads place greater barriers on tiger dispersal than distance, according to new research published ...

Lower education levels linked to unhealthy diets

2013-11-07
Lower education levels linked to unhealthy diets Higher physical activity in less-educated people is related to unhealthy diets People with lower levels of education may eat larger amounts of unhealthy, calorically dense food than those with a higher education level, ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Discovery of HIV 'invisibility cloak' reveals new treatment opportunities